Non-invasive imaging and cellular tracking of pulmonary emboli by near-infrared fluorescence and positron-emission tomography

Functional imaging of proteolytic activity is an emerging strategy to quantify disease and response to therapy at the molecular level. We present a new peptide-based imaging probe technology that advances these goals by exploiting enzymatic activity to deposit probes labelled with near-infrared (NIR) fluorophores or radioisotopes in cell membranes of disease-associated proteolysis. This strategy allows for non-invasive detection of protease activity in vivo and ex vivo by tracking deposited probes in tissues. We demonstrate non-invasive detection of thrombin generation in a murine model of pulmonary embolism using our protease-activated peptide probes in microscopic clots within the lungs with NIR fluorescence optical imaging and positron-emission tomography. Thrombin activity is imaged deep in tissue and tracked predominantly to platelets within the lumen of blood vessels. The modular design of our probes allows for facile investigation of other proteases, and their contributions to disease by tailoring the protease activation and cell-binding elements.

[1]  H. Hanson.  Proteolytic enzymes. , 1962, Experimental eye research.

[2]  A. Berger,et al.  On the size of the active site in proteases. I. Papain. , 1967, Biochemical and biophysical research communications.

[3]  H. Lankinen,et al.  Comparison of synthesis and antibacterial activity of temporin A , 1999, FEBS letters.

[4]  D. Fairlie,et al.  Conformational homogeneity in molecular recognition by proteolytic enzymes , 1999, Journal of molecular recognition : JMR.

[5]  C. Craik,et al.  Rapid and general profiling of protease specificity by using combinatorial fluorogenic substrate libraries. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[6]  B. L. Le Bonniec,et al.  The dual role of thrombin's anion-binding exosite-I in the recognition and cleavage of the protease-activated receptor 1. , 2001, European journal of biochemistry.

[7]  E. Di Cera,et al.  Molecular mapping of thrombin‐receptor interactions , 2001, Proteins.

[8]  L. Hedstrom.  Serine protease mechanism and specificity. , 2002, Chemical reviews.

[9]  S. Coughlin,et al.  Protection against thrombosis in mice lacking PAR3. , 2002, Blood.

[10]  Vasilis Ntziachristos,et al.  In Vivo Imaging of Proteolytic Activity in Atherosclerosis , 2002, Circulation.

[11]  R. Weissleder,et al.  In Vivo Imaging of Thrombin Activity in Experimental Thrombi With Thrombin-Sensitive Near-Infrared Molecular Probe , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[12]  N. Papo,et al.  Effects of the antimicrobial peptide temporin L on cell morphology, membrane permeability and viability of Escherichia coli. , 2004, The Biochemical journal.

[13]  Roger Y Tsien,et al.  Tumor imaging by means of proteolytic activation of cell-penetrating peptides. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Gore,et al.  Noninvasive Detection of Matrix Metalloproteinase Activity In Vivo using a Novel Magnetic Resonance Imaging Contrast Agent with a Solubility Switch , 2007, Molecular imaging.

[15]  B. Sos,et al.  Sex differences in thrombosis in mice are mediated by sex-specific growth hormone secretion patterns. , 2008, The Journal of clinical investigation.

[16]  M. Bogyo,et al.  Comparative Assessment of Substrates and Activity Based Probes as Tools for Non-Invasive Optical Imaging of Cysteine Protease Activity , 2009, PloS one.

[17]  Xia Li,et al.  APD2: the updated antimicrobial peptide database and its application in peptide design , 2008, Nucleic Acids Res..

[18]  Roger Y Tsien,et al.  Systemic in vivo distribution of activatable cell penetrating peptides is superior to that of cell penetrating peptides. , 2009, Integrative biology : quantitative biosciences from nano to macro.

[19]  Gonzalo R. Ordóñez,et al.  The Degradome database: mammalian proteases and diseases of proteolysis , 2008, Nucleic Acids Res..

[20]  Roger Y Tsien,et al.  In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer. , 2009, Integrative biology : quantitative biosciences from nano to macro.

[21]  Xiaoyuan Chen,et al.  Apoptosis Imaging: Beyond Annexin V , 2010, The Journal of Nuclear Medicine.

[22]  C. Esmon,et al.  The Endothelial Protein C Receptor Supports Tissue Factor Ternary Coagulation Initiation Complex Signaling through Protease-activated Receptors* , 2010, The Journal of Biological Chemistry.

[23]  Ralph Weissleder,et al.  Near-infrared fluorescence: application to in vivo molecular imaging. , 2010, Current opinion in chemical biology.

[24]  E. Di Cera,et al.  Crystal Structure of Thrombin Bound to the Uncleaved Extracellular Fragment of PAR1* , 2010, The Journal of Biological Chemistry.

[25]  S. Grinstein,et al.  The distribution and function of phosphatidylserine in cellular membranes. , 2010, Annual review of biophysics.

[26]  M. Bogyo,et al.  Functional imaging of proteases: recent advances in the design and application of substrate-based and activity-based probes. , 2011, Current opinion in chemical biology.

[27]  P. Libby,et al.  Molecular imaging of macrophage protease activity in cardiovascular inflammation in vivo , 2011, Thrombosis and Haemostasis.

[28]  K. Nicolay,et al.  Tumor Targeting of MMP-2/9 Activatable Cell-Penetrating Imaging Probes Is Caused by Tumor-Independent Activation , 2011, The Journal of Nuclear Medicine.

[29]  Vikesh K. Singh,et al.  Comparative analysis of traditional and coiled fiducials implanted during EUS for pancreatic cancer patients receiving stereotactic body radiation therapy. , 2012, Gastrointestinal endoscopy.

[30]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association. , 2012, Circulation.

[31]  R. Tsien,et al.  In vivo fluorescence imaging of atherosclerotic plaques with activatable cell-penetrating peptides targeting thrombin activity. , 2012, Integrative biology : quantitative biosciences from nano to macro.

[32]  Jennifer A. Getz,et al.  Identifi cation of protease exosite-interacting peptides that enhance substrate cleavage kinetics , 2012, Biological chemistry.

[33]  A. Haimovitz-Friedman,et al.  Anticancer therapy and apoptosis imaging. , 2012, Experimental oncology.

[34]  Oliver Gaemperli,et al.  Non-invasive anatomic and functional imaging of vascular inflammation and unstable plaque. , 2012, European heart journal.

[35]  S. Diamond,et al.  Platelet‐targeting sensor reveals thrombin gradients within blood clots forming in microfluidic assays and in mouse , 2012, Journal of thrombosis and haemostasis : JTH.

[36]  R. Silverstein,et al.  Ferric chloride-induced murine carotid arterial injury: A model of redox pathology☆ , 2013, Redox biology.

[37]  R. Tsien,et al.  Ratiometric Activatable Cell-Penetrating Peptides Provide Rapid In Vivo Readout of Thrombin Activation** , 2012, Angewandte Chemie.

[38]  K. Mann,et al.  The role of the red cell membrane in thrombin generation. , 2013, Thrombosis research.

[39]  W. Lam,et al.  Factor XIII activity mediates red blood cell retention in venous thrombi. , 2014, Journal of Clinical Investigation.

[40]  A. Lourenço,et al.  In vitro and in vivo analysis of the antithrombotic and toxicological profile of new antiplatelets N-acylhydrazone derivatives and development of nanosystems: determination of novel NAH derivatives antiplatelet and nanotechnological approach. , 2014, Thrombosis research.

[41]  H. Castro,et al.  Synthesis and Antiplatelet Activity of Antithrombotic Thiourea Compounds: Biological and Structure-Activity Relationship Studies , 2015, Molecules.

[42]  Ahmed Tawakol,et al.  Imaging Atherosclerosis , 2016, Circulation research.